Resmed share price logo

Resmed

NYSE: RMD

Large Cap

$221.29

-1.54

(-0.69%)

as on

Resmed Stock Performance

as on October 1, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $220.58
    $224.04
    downward going graph

    0.32%

    Downside

    1.24%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $180.27
    $284.87
    downward going graph

    18.54%

    Downside

    28.73%

    Upside

    downward going graph

Resmed share price movements today

Previous Close
$222.83
Open
$222.63
Volume
807.2K
Market Cap
$32.0B
Dividend Yield
1.11%
Day's Low - High
$220.58 - $224.04
52 Week Low - High
$180.27 - $284.87

Resmed Historical Returns

1 Month Return
-7.59 %
3 Month Return
+ 11.93 %
1 Year Return
-18.06 %
3 Year Return
+ 50.2 %
5 Year Return
-16.3 %

Resmed Stock Fundamentals & Key Indicators

Check Resmed market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$32.0B

EPS (TTM)

10.44

Dividend Yield

1.11%

Quarterly Earnings Growth YOY

0.02%

PE Ratio (TTM)

21.26

Industry PE ratio

24.14

PEG Ratio

2.28

EBITDA

2.1B

Revenue (TTM)

5.7B

Profit Margin

61.16%

Return On Equity TTM

23.88%

Resmed vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Resmed with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Neutral$32.0B-16.30%21.2661.16%1.11%
StrongBuy$148.6B24.38%46.8766.68%0.00%
Buy$50.1B-25.97%55.3746.12%2.16%
StrongBuy$47.2BNA40.7825.02%0.00%

Stock Returns calculator for Resmed Stock including INR - Dollar returns

The Resmed stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Resmed investment value today

Current value as on today

₹88,064

Returns

-₹11,936

(-11.94%)

Returns from Resmed Stock

-₹18,358 (-18.36%)

Dollar Impact

₹6,423 (+6.42%)

Analyst Recommendation on Resmed Stock

Based on 7 analysts

HOLD

14.29%

Buy

85.71%

Hold

0.00%

Sell

Based on 7 analysts, 85.71428571428571% of analysts recommend a 'HOLD' rating for Resmed. Average target price of $250.22

Resmed Share Price Target

Get share price movements and forecasts by analysts on Resmed.

What analysts predicted

11.56%UPSIDE

Target Price

$250.22

Current Price

$221.29

Analyzed by

7 Analysts

High

$235

Target

$250.22

Low

$213

Resmed target price $250.22, a slight upside of 11.56% compared to current price of $221.29. According to 7 analysts rating.

Indian Investors' Interest in Resmed Stock

Search interest for Resmed Stock has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-56% versus previous 30 day period

Resmed Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1,196
1,223
1,224
1,282
1,291
1,347
1,335
1,422
1,431
1,463
Gross Profit
681
704
717
751
766
820
820
884
890
861
Operating Income
374
381
387
417
426
454
446
497
499
448
EBITDA
444
362
442
479
469
532
503
566
583
492
Interest Expense
14
9
5
4
3
-
8
7
12
-
Depreciation
54
54
53
55
51
74
47
62
69
18
Income Before Tax
375
357
383
418
417
458
446
496
502
474
Income Tax Expense
74
65
72
73
52
78
98
103
103
90
Net Income
300
292
311
344
365
379
348
392
398
383
Net Profit Margin
56.94%
57.58%
58.57%
58.60%
59.33%
60.84%
61.46%
62.18%
62.25%
58.84%

Resmed Annual Profit & Loss

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Jun 2026
Total Revenue
2,066
2,340
2,606
2,957
3,196
3,578
4,222
4,685
5,146
5,653
Gross Profit
1,201
1,362
1,536
1,717
1,839
2,024
2,355
2,655
3,054
3,457
Operating Income
425
541
579
809
903
1,000
1,131
1,319
1,685
1,892
EBITDA
568
680
705
990
1,103
1,176
1,358
1,533
1,913
2,146
Interest Expense
28
28
36
40
23
22
47
45
12
29
Depreciation
112
119
150
181
191
193
196
216
235
197
Income Before Tax
418
521
518
733
883
960
1,101
1,264
1,677
1,919
Income Tax Expense
76
205
114
111
409
181
204
243
276
396
Net Income
342
315
404
621
474
779
897
1,020
1,400
1,523
Net Profit Margin
58.15%
58.21%
58.95%
58.09%
57.53%
56.57%
55.78%
56.67%
59.36%
61.16%

Resmed Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
300
292
311
344
365
379
348
392
398
1,523
Operating Cash Flow
402
440
325
308
578
538
457
339
554
1,805
Investing Cash Flow
-33
-46
2
-36
-31
-133
-52
-50
-58
-545
Financing Cash Flow
-335
-393
-150
-147
-144
-163
-230
-258
-255
-1,007
Change in Cash
27
0
188
95
410
276
174
33
243
259

Resmed Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Jun 2026
Net Income
342
315
404
621
474
779
897
1,020
1,400
1,523
Operating Cash Flow
414
505
459
802
736
351
693
1,401
1,751
1,805
Investing Cash Flow
-81
-101
-1,075
-179
-158
-229
-1,159
-269
-200
-545
Financing Cash Flow
-262
-1,026
580
-317
-764
-128
422
-1,119
-606
-1,007
Change in Cash
90
-633
-41
316
-167
-21
-45
10
971
259

Global Institutional Holdings in Resmed

Check out the Institutions with significant holdings in Resmed.

Funds
Holdings
Vanguard
11.73%
VANGUARD INDEX FUNDS
10.05%
iShares
5.63%
SPDR
4.04%
First Trust
1.83%

Resmed News & Key Events

  • img

    Today's Timeline - 15 September

    Tue, 07:11 PM

    -

    RBC Capital upgrades ResMed to Outperform with a price target increase to $262, citing growth potential in sleep apnea market.

    Tue, 07:40 PM

    -

    ResMed's portfolio reduction in Residential Care Software supports growth; however, macroeconomic pressures pose operational risks.

Insights on Resmed

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, RMD has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, RMD stock has moved up by 10.8%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 1.33B → 1.46B (in $), with an average increase of 3.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, ResMed Inc. has experienced a drawdown of -17.7%, however Becton, Dickinson and Co. resisted the overall trend and outperformed by 13.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 398.73M → 383.43M (in $), with an average decrease of 3.8% per quarter

About Resmed

ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
OrganisationResmed
Headquarters9001 Spectrum Center Boulevard, San Diego, CA, 92123, US
IndustryMedical - Instruments & Supplies
CEOMichael J. Farrell

Key Management of Resmed

Name

Title

Mr. Michael J. Rider

Chief Legal Officer & Secretary

Mr. Justin Leong

Chief Product Officer

Mr. Alastair Robertson

Chief Information Officer

Mr. Jim Ellis

Chief Compliance Officer

Ms. Yvonne-Katrin Pucknat

Chief Marketing Officer

Mr. Michael J. Farrell BE, MBA, SM

CEO & Chairman

Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD

Founder, Chair Emeritus & Non-Executive Director

Ms. Vered Keisar

Chief People Officer

Mr. Brett A. Sandercock

Advisor

Mr. Aaron Bloomer

Chief Financial Officer

FAQs

What is Resmed share price today?

Resmed share price today is $221.29 as on at the close of the market. Resmed share today touched a day high of $224.04 and a low of $220.58.

What is the 52 week high and 52 week low for Resmed share?

Resmed share touched a 52 week high of $284.87 on and a 52 week low of $180.27 on . Resmed stock price today i.e. is closed at $221.29,which is 22.32% down from its 52 week high and 22.76% up from its 52 week low.

What is Resmed's market capitalisation today?

Resmed market capitalisation is $0.03T as on .

How to invest in Resmed Stock (RMD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Resmed on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Resmed Stock (RMD) from India?

Indian investors can start investing in Resmed (RMD) shares with as little as ₹95.83000183105469 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.30 in Resmed stock (as per the Rupee-Dollar exchange rate as on ). Based on Resmed share’s latest price of $221.29 as on October 1, 2026 at 1:29 am IST, you will get 0.0452 shares of Resmed. Learn more about fractional shares .

What are the returns that Resmed has given to Indian investors in the last 5 years?

Resmed stock has given -16.3% share price returns and 29.42% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?